
  
    
      
        Background_NNP
        Endochondral_NNP ossification_NN is_VBZ the_DT process_NN by_IN which_WDT
        mesenchymal_NN cells_NNS condense_NN at_IN specific_JJ sites_NNS and_CC
        differentiate_VB into_IN chondrocytes_NNS ,_, forming_VBG the_DT cartilage_NN
        anlagen_NN that_WDT are_VBP the_DT model_NN for_IN the_DT future_JJ bone_NN ._. The_DT cells_NNS
        in_IN the_DT center_NN of_IN the_DT anlagen_NN ,_, which_WDT are_VBP initially_RB immature_NN ,_,
        undergo_VBP an_DT ordered_VBN differentiation_NN program_NN [_NN 2_CD ]_NN (_( also_RB
        called_VBN chondrocyte_NN maturation_NN [_NN 3_CD ]_NN )_) :_: the_DT chondrocytes_NNS
        proliferate_VBP ,_, become_VB pre-hypertrophic_JJ ,_, and_CC then_RB undergo_VBP
        hypertrophy_NN and_CC matrix_NN calcification_NN ._. The_DT calcified_JJ
        cartilage_NN is_VBZ then_RB invaded_VBD by_IN blood_NN vessels_NNS that_WDT bring_VBP
        osteoblasts_NNS and_CC osteoclasts_NNS ,_, and_CC bone_NN is_VBZ formed_VBN ._. Each_DT step_NN
        of_IN cartilage_NN maturation_NN occurs_VBZ in_IN a_DT precise_JJ and_CC tightly_RB
        regulated_VBN manner_NN [_NN 4_CD ]_NN ._. Disruptions_NNP of_IN this_DT process_NN cause_NN
        abnormalities_NNS in_IN cartilage_NN and_CC bone_NN formation_NN [_NN 5_CD 6_CD ]_NN ._.
        Endochondral_NNP ossification_NN occurs_VBZ in_IN embryonic_JJ skeletal_NN
        formation_NN ,_, in_IN skeletal_NN growth_NN and_CC fracture_NN healing_NN ._.
        Homeobox_NNP genes_NNS of_IN the_DT Hox_NNP class_NN are_VBP required_VBN for_IN proper_JJ
        patterning_VBG of_IN skeletal_NN elements_NNS [_NN 7_CD ]_NN ._. The_DT functional_JJ role_NN
        of_IN Hox_NNP genes_NNS in_IN skeletal_NN growth_NN and_CC development_NN has_VBZ been_VBN
        clearly_RB demonstrated_VBN ,_, but_CC how_WRB they_PRP control_VBP the_DT
        differentiation_NN of_IN specific_JJ tissues_NNS is_VBZ not_RB well_RB understood_VBN ._.
        Hox_NNP genes_NNS encode_NN transcription_NN factors_NNS that_WDT regulate_VB the_DT
        expression_NN of_IN yet_RB unidentified_JJ target_NN genes_NNS [_NN 8_CD ]_NN ._. In_IN
        order_NN to_TO identify_VB such_JJ target_NN genes_NNS and_CC to_TO better_JJR
        understand_VB the_DT role_NN of_IN Hox_NNP genes_NNS in_IN cartilage_NN
        differentiation_NN and_CC maturation_NN ,_, we_PRP established_VBD 
        in_IN vitro_NN culture_NN systems_NNS for_IN primary_JJ
        mouse_NN rib_NN chondrocytes_NNS ._.
        Previously_RB ,_, we_PRP generated_VBD transgenic_JJ mice_NNS that_IN
        overexpress_NNS the_DT homeobox_NN transcription_NN factor_NN Hoxc-_NNP 8_CD in_IN the_DT
        thoracic_JJ region_NN ,_, where_WRB Hoxc-_NNP 8_CD is_VBZ normally_RB expressed_VBN (_( [_NN 1_CD ]_NN
        and_CC unpublished_JJ results_NNS )_) ._. The_DT transgenic_JJ mice_NNS exhibit_NN
        profound_JJ cartilage_NN defects_NNS ,_, predominantly_RB in_IN ribs_NNS and_CC
        vertebral_NN column_NN ,_, and_CC severity_NN of_IN defects_NNS depends_VBZ on_IN
        transgene_NN dosage_NN ._. The_DT abnormal_JJ cartilage_NN is_VBZ characterized_VBN
        by_IN an_DT accumulation_NN of_IN proliferating_VBG chondrocytes_NNS and_CC
        reduced_VBN cartilage_NN maturation_NN ._. The_DT structural_JJ rigidity_NN of_IN
        rib_NN cartilage_NN is_VBZ greatly_RB compromised_VBN ,_, fatally_RB interfering_VBG
        with_IN pulmonary_JJ function_NN ,_, and_CC vertebral_NN cartilage_NN is_VBZ so_RB weak_JJ
        that_IN the_DT skeleton_NN often_RB disassembles_NNS during_IN skeletal_NN
        preparation_NN [_NN 1_CD ]_NN ._. These_DT results_NNS suggest_VBP that_IN Hoxc-_NNP 8_CD
        continues_VBZ to_TO regulate_VB skeletal_NN development_NN well_RB beyond_IN
        pattern_NN formation_NN in_IN a_DT tissue-specific_JJ manner_NN ,_, presumably_RB
        by_IN controlling_VBG the_DT progression_NN of_IN cells_NNS along_IN the_DT
        chondrocyte_NN differentiation_NN pathway_NN ._. We_PRP found_VBD a_DT similar_JJ
        phenotype_NN upon_IN overexpression_NN of_IN Hoxd-_NNP 4_CD in_IN our_PRP$ transgenic_JJ
        system_NN (_( Kappen_NNP ,_, manuscript_NN in_IN preparation_NN )_) ,_, whereas_IN
        overexpression_NN of_IN the_DT LIM-homeodomain_NNP transcription_NN factor_NN
        Isl-_NNP 1_CD did_VBD not_RB cause_VB abnormalities_NNS in_IN cartilage_NN but_CC other_JJ
        developmental_NN defects_NNS [_NN 1_CD 9_CD ]_NN ._. The_DT observation_NN that_DT
        cartilage_NN is_VBZ affected_VBN by_IN misregulation_NN of_IN Hoxc-_NNP 8_CD and_CC
        Hoxd-_NNP 4_CD ,_, but_CC not_RB by_IN a_DT divergent_JJ homeobox_NN gene_NN ,_, indicates_VBZ
        that_IN the_DT capacity_NN to_TO regulate_VB cartilage_NN differentiation_NN is_VBZ
        specific_JJ to_TO homeobox_NN genes_NNS of_IN the_DT Hox_NNP subclass_NNS ._. It_PRP also_RB
        suggests_VBZ that_IN Hox_NNP genes_NNS could_MD be_VB involved_VBN in_IN human_JJ
        chondrodysplasias_NNS and_CC other_JJ cartilage_NN disorders_NNS ._. We_PRP
        envisioned_VBN that_IN well-defined_JJ 
        in_IN vitro_NN culture_NN systems_NNS would_MD allow_VB
        us_PRP to_TO further_VB characterize_VB the_DT cellular_JJ and_CC molecular_JJ basis_NN
        of_IN abnormal_JJ chondrocyte_NN differentiation_NN in_IN Hox_NNP transgenic_JJ
        mice_NNS ._. Detailed_NNP knowledge_NN of_IN regulatory_JJ mechanisms_NNS in_IN
        endochondral_NN ossification_NN will_MD be_VB essential_JJ for_IN strategies_NNS
        to_TO manipulate_VB chondrocyte_NN proliferation_NN ,_, differentiation_NN
        and_CC maturation_NN in_IN skeletal_NN growth_NN and_CC development_NN ,_,
        osteochondrodysplasias_NNS and_CC fracture_NN healing_NN ._.
        The_DT 
        in_IN vitro_NN chondrocyte_NN culture_NN systems_NNS
        we_PRP utilized_JJ here_RB consisted_VBD of_IN high-density_JJ cultures_NNS of_IN
        primary_JJ rib_NN chondrocytes_NNS from_IN neonatal_NN mice_NNS ._. The_DT micromass_NNS
        culture_NN system_NN [_NN 10_CD ]_NN provides_VBZ the_DT three-dimensional_JJ
        environment_NN needed_VBN for_IN chondrogenesis_NNS ,_, cartilage_NN maturation_NN
        and_CC hypertrophy_NN ._. The_DT system_NN also_RB allows_VBZ the_DT investigation_NN
        of_IN the_DT continuous_JJ program_NN of_IN differentiation_NN ,_, maturation_NN
        and_CC hypertrophy_NN in_IN the_DT same_JJ culture_NN ._. The_DT cellular_JJ phenotype_NN
        in_IN culture_NN was_VBD characterized_VBN by_IN morphology_NN and_CC
        extra-cellular_JJ matrix_NN (_( ECM_NNP )_) production_NN ._. Chondrocyte_NNP
        maturation_NN was_VBD assessed_VBN on_IN the_DT basis_NN of_IN cell_NN proliferation_NN ,_,
        cellular_JJ hypertrophy_NN ,_, alkaline_NN phosphase_NN activity_NN and_CC
        expression_NN of_IN Collagen_NNP type_NN II_NNP and_CC type_NN X_NNP ._. Apoptosis_NNP was_VBD
        investigated_VBN by_IN TUNEL_NNP (_( terminal_NN deoxynucleotidyl_NN
        transferase-mediated_JJ deoxyuridine_NN triposphate_NN nick_NN end_NN
        labeling_VBG )_) ._. High_JJ density_NN bulk_NN cultures_NNS were_VBD used_VBN to_TO assess_VB
        the_DT capacity_NN of_IN chondrocytes_NNS from_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS
        for_IN cell_NN proliferation_NN and_CC differentiation_NN ._. Proliferation_NNP
        of_IN chondrocytes_NNS 
        in_IN vivo_NN was_VBD assayed_JJ by_IN BrdU_NNP
        incorporation_NN ,_, and_CC gene_NN expression_NN was_VBD analyzed_VBN by_IN
        real-time_JJ quantitative_JJ PCR_NNP ._.
      
      
        Results_NNS
        We_PRP previously_RB reported_VBD [_NN 1_CD ]_NN that_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS
        exhibit_NN profound_JJ defects_NNS in_IN cartilage_NN ,_, particularly_RB in_IN the_DT
        rib_NN cage_NN and_CC vertebral_NN column_NN ._. The_DT cartilage_NN is_VBZ
        structurally_RB insufficient_JJ and_CC weak_JJ ,_, contains_VBZ fewer_RBR
        hypertrophic_JJ chondrocytes_NNS ,_, displays_NNS much_RB reduced_VBN staining_VBG
        for_IN sulfated_JJ proteoglycans_NNS ,_, and_CC consists_VBZ predominantly_RB of_IN
        immature_NN chondrocytes_NNS ,_, with_IN a_DT high_JJ fraction_NN of_IN
        proliferating_VBG cells_NNS ._. These_DT results_NNS point_VBP to_TO a_DT role_NN of_IN
        Hoxc-_NNP 8_CD in_IN regulation_NN of_IN cartilage_NN maturation_NN and_CC
        chondrocyte_NN differentiation_NN ._. A_DT similar_JJ phenotype_NN is_VBZ found_VBN
        in_IN Hoxd-_NNP 4_CD transgenic_JJ mice_NNS (_( [_NN 1_CD ]_NN and_CC Kappen_NNP ,_, manuscript_NN in_IN
        preparation_NN )_) indicating_VBG that_IN Hox_NNP transcription_NN factors_NNS
        regulate_VB chondrocyte_NN development_NN ._. To_TO examine_VB this_DT function_NN
        in_IN more_JJR detail_NN ,_, we_PRP employed_VBN a_DT culture_NN system_NN that_IN
        facilitates_NNS chondrocyte_NN maturation_NN and_CC cartilage_NN formation_NN ,_,
        and_CC closely_RB recapitulates_NNS the_DT 
        in_IN vivo_NN situation_NN [_NN 11_CD ]_NN ._. The_DT
        micromass_NNS system_NN has_VBZ been_VBN used_VBN extensively_RB for_IN studies_NNS of_IN
        cartilage_NN formation_NN from_IN limb_NN mesenchyme_NN [_NN 10_CD 11_CD 12_CD 13_CD ]_NN
        and_CC also_RB for_IN culture_NN of_IN chondrocytes_NNS in_IN high_JJ density_NN [_NN 14_CD ]_NN
        ._. Here_RB ,_, we_PRP have_VBP adapted_VBN the_DT system_NN to_TO neonatal_NN mouse_NN rib_NN
        chondrocytes_NNS ,_, to_TO study_VB the_DT role_NN of_IN Hoxc-_NNP 8_CD in_IN chondrocyte_NN
        maturation_NN ._.
        As_IN established_VBN previously_RB ,_, chondrocytes_NNS in_IN micromass_NNS
        culture_NN are_VBP able_JJ to_TO progress_VB along_IN their_PRP$ differentiation_NN
        pathway_NN to_TO hypertrophy_NN [_NN 14_CD ]_NN ._. In_IN cultures_NNS of_IN neonatal_NN rib_NN
        chondrocytes_NNS ,_, we_PRP find_VBP essentially_RB the_DT same_JJ results_NNS ._. As_IN
        shown_VBN in_IN Figure_NN 1_CD ,_, histology_NN (_( Panels_NNP A_DT and_CC E_NNP )_) and_CC
        immunohistochemistry_NN for_IN Collagens_NNP II_NNP and_CC X_NNP (_( Figure_NN 1_CD ,_,
        Panels_NNP C_NNP ,_, D_NNP and_CC G_NNP ,_, H_NNP )_) revealed_VBD appropriate_JJ cellular_JJ
        morphology_NN ,_, as_RB well_RB as_IN increase_NN in_IN cell_NN size_NN towards_IN
        hypertrophy_NN (_( Figure_NN 1_CD ,_, Panels_NNP E_NNP ,_, G_NNP ,_, H_NNP )_) ,_, and_CC extracellular_NN
        matrix_NN production_NN (_( Figure_NN 1_CD ,_, Panel_NNP F_NNP )_) ._. BrdU_NNP incorporation_NN
        identified_VBD proliferating_VBG cells_NNS early_RB in_IN the_DT culture_NN (_( Figure_NN
        1_CD ,_, Panels_NNP J_NNP ,_, K_NNP )_) ,_, while_IN virtually_RB no_DT dividing_VBG cells_NNS were_VBD
        detected_VBN by_IN day_NN 15_CD (_( Figure_NN 1_CD ,_, Panel_NNP L_NNP )_) ._. The_DT proportion_NN of_IN
        proliferating_VBG cells_NNS was_VBD lower_JJR at_IN the_DT beginning_NN of_IN the_DT
        culture_NN (_( Figure_NN 2_CD ,_, Panel_NNP A_DT )_) ,_, reflecting_VBG our_PRP$ observation_NN
        that_IN cells_NNS may_MD need_NN about_IN 1_CD -_: 2_CD days_NNS to_TO adapt_VB to_TO the_DT culture_NN
        conditions_NNS ._. Maximal_NNP proliferation_NN was_VBD found_VBN on_IN days_NNS 3_CD and_CC
        4_CD ,_, consistent_JJ with_IN the_DT presence_NN of_IN predominantly_RB
        proliferating_VBG cells_NNS in_IN the_DT culture_NN (_( compare_VB Figure_NN 2_CD ,_, Panel_NNP
        A_DT and_CC Figure_NN 1_CD ,_, Panel_NNP I_PRP )_) ._. Manifesting_NNP their_PRP$ progression_NN to_TO
        hypertrophy_NN ,_, the_DT size_NN of_IN cells_NNS increased_VBN (_( Figure_NN 2_CD ,_, Panel_NNP
        B_NNP )_) ,_, with_IN the_DT majority_NN of_IN cells_NNS progressed_VBD to_TO hypertrophy_NN by_IN
        day_NN 15_CD (_( see_VB also_RB Figure_NN 1_LS )_) ._. Concommittant_NNP with_IN cartilage_NN
        ECM_NNP deposition_NN ,_, there_EX was_VBD an_DT increase_NN in_IN Alkaline_NNP
        Phosphotase_NNP activity_NN (_( Figure_NN 2_CD ,_, Panel_NNP C_NNP )_) ._. As_IN cells_NNS matured_VBN
        towards_IN hypertrophy_NN ,_, there_EX was_VBD also_RB increased_VBN cell_NN death_NN in_IN
        our_PRP$ micromass_NNS cultures_NNS (_( Figure_NN 2_CD ,_, Panel_NNP D_NNP )_) ._. Apoptosis_NNP ,_, as_IN
        assessed_VBN by_IN TUNEL_NNP ,_, was_VBD present_JJ from_IN day_NN 3_CD on_IN ,_, and_CC the_DT
        percentage_NN of_IN positive_JJ cells_NNS increased_VBN with_IN time_NN in_IN
        culture_NN ._. Similar_JJ results_NNS were_VBD reported_VBN by_IN other_JJ authors_NNS [_NN
        15_CD 16_CD 17_CD ]_NN ._. These_DT results_NNS demonstrate_VBP that_IN the_DT cultured_JJ
        rib_NN chondrocytes_NNS behaved_VBD in_IN a_DT similar_JJ manner_NN as_IN
        chondrocytes_NNS 
        in_IN vivo_NN ._. Taken_VBN together_RB ,_, primary_JJ rib_NN
        chondrocytes_NNS from_IN mouse_NN neonates_NNS grown_VBN in_IN micromass_NNS culture_NN
        display_NN cellular_JJ differentiation_NN ,_, proliferation_NN ,_, maturation_NN
        and_CC hypertrophy_NN ,_, recapitulating_VBG the_DT chondrocyte_NN maturation_NN
        program_NN 
        in_IN vivo_NN ._. These_DT results_NNS establish_VB the_DT
        utility_NN of_IN this_DT 
        in_IN vitro_NN system_NN to_TO investigate_VB the_DT
        role_NN of_IN Hox_NNP genes_NNS and_CC other_JJ transcription_NN factors_NNS in_IN
        endochondral_NN ossification_NN ._.
        Rib_NNP chondrocytes_NNS from_IN neonatal_NN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS
        were_VBD cultured_JJ in_IN the_DT micromass_NNS system_NN ,_, and_CC the_DT cultures_NNS
        were_VBD examined_VBN for_IN the_DT same_JJ parameters_NNS described_VBD above_IN ._.
        Figure_NN 3_CD shows_VBZ that_IN Hoxc-_NNP 8_CD transgenic_JJ chondrocytes_NNS
        morphologically_RB appeared_VBD normal_JJ and_CC were_VBD able_JJ to_TO produce_VB
        Collagens_NNP II_NNP and_CC X_NNP ,_, and_CC sulfated_JJ proteoglycans_NNS (_( Panels_NNP C_NNP ,_,
        G_NNP ,_, I_PRP ,_, D_NNP ,_, H_NNP ,_, J_NNP and_CC B_NNP ,_, F_NN respectively_RB )_) ._. There_EX was_VBD no_DT
        discernable_JJ difference_NN in_IN the_DT ability_NN of_IN Hoxc-_NNP 8_CD transgenic_JJ
        chondrocytes_NNS to_TO grow_VB or_CC mature_VBP in_IN this_DT system_NN (_( compare_VB to_TO
        Figure_NN 1_CD ,_, Panels_NNP A-H_NNP )_) ._. These_DT data_NNS indicate_VBP that_IN
        chondrocytes_NNS from_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS have_VBP the_DT capacity_NN
        to_TO differentiate_VB and_CC mature_VBP normally_RB under_IN the_DT culture_NN
        conditions_NNS described_VBD here_RB ._. This_DT finding_VBG was_VBD unexpected_JJ in_IN
        light_NN of_IN the_DT severe_JJ cartilage_NN defects_NNS in_IN Hoxc-_NNP 8_CD transgenic_JJ
        mice_NNS [_NN 1_CD ]_NN ._. However_RB ,_, the_DT possibility_NN remained_VBD that_IN ,_,
        despite_IN apparently_RB normal_JJ maturation_NN ,_, proliferation_NN of_IN
        chondrocytes_NNS could_MD be_VB affected_VBN by_IN the_DT Hoxc-_NNP 8_CD
        overexpression_NN ._. Such_JJ an_DT effect_NN would_MD be_VB consistent_JJ with_IN the_DT
        accumulation_NN of_IN immature_NN ,_, proliferating_VBG chondrocytes_NNS in_IN
        Hoxc-_NNP 8_CD transgenetic_JJ mice_NNS [_NN 1_CD ]_NN ._. We_PRP therefore_RB characterized_VBD
        cell_NN proliferation_NN in_IN Hoxc-_NNP 8_CD transgenic_JJ chondrocytes_NNS ._.
        
        In_IN vivo_NN labeling_VBG with_IN BrdU_NNP was_VBD
        performed_VBN to_TO investigate_VB the_DT proliferative_JJ status_NN of_IN
        chondrocytes_NNS in_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS ._. Previously_RB ,_, we_PRP [_NN 1_CD
        ]_NN found_VBD that_IN upon_IN overexpression_NN of_IN Hoxc-_NNP 8_CD ,_, the_DT vertebral_NN
        cartilages_NNS accumulate_VBP immature_NN chondrocytes_NNS ,_, and_CC we_PRP showed_VBD
        that_IN these_DT cells_NNS are_VBP proliferating_VBG cells_NNS by_IN virtue_NN of_IN
        staining_VBG for_IN Proliferating_NNP Cell_NNP Nuclear_NNP Antigen_NNP (_( PCNA_NNP )_) ._. The_DT
        accumulation_NN of_IN proliferating_VBG chondrocytes_NNS could_MD be_VB
        explained_VBN in_IN four_CD different_JJ scenarios_NNS :_: (_( 
        i_NNP )_) There_EX is_VBZ a_DT block_NN in_IN differentiation_NN
        that_WDT prevents_VBZ cells_NNS from_IN entering_VBG hypertrophy_NN ._. The_DT
        proportion_NN of_IN hypertrophic_JJ cells_NNS was_VBD indeed_RB reduced_VBN in_IN
        Hoxc-_NNP 8_CD transgenic_JJ mice_NNS ,_, but_CC progression_NN to_TO hypertrophy_NN was_VBD
        not_RB completely_RB inhibited_VBD ._. (_( 
        ii_NN )_) There_EX is_VBZ increased_VBN recruitment_NN of_IN
        precursor_NN cells_NNS into_IN the_DT chondrocyte_NN cell_NN lineage_NN ._. This_DT
        proposition_NN is_VBZ difficult_JJ to_TO investigate_VB ,_, and_CC no_DT evidence_NN is_VBZ
        available_JJ at_IN this_DT stage_NN ._. (_( 
        iii_NN )_) The_DT rate_NN of_IN cell_NN division_NN is_VBZ
        increased_VBN ._. Then_RB ,_, the_DT cell_NN cycle_NN duration_NN of_IN proliferating_VBG
        chondrocytes_NNS should_MD be_VB shorter_JJR ._. (_( 
        iv_NN )_) The_DT cell_NN cycle_NN time_NN of_IN
        proliferating_VBG chondrocytes_NNS is_VBZ lengthened_VBN ,_, resulting_VBG in_IN a_DT
        greater_JJR number_NN of_IN cells_NNS in_IN the_DT steady-state_JJ pool_NN of_IN
        proliferating_VBG cells_NNS ._. To_TO distinguish_VB these_DT latter_JJ two_CD
        possibilities_NNS ,_, we_PRP analyzed_VBD BrdU_NNP incorporation_NN into_IN
        chondrocytes_NNS in_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS 
        in_IN vivo_NN ._. Multiple_NNP sections_NNS were_VBD
        examined_VBN from_IN each_DT embryo_NN and_CC showed_VBD incorporation_NN of_IN BrdU_NNP
        four_CD hours_NNS after_IN labeling_VBG ._. Figure_NN 4_CD shows_VBZ representative_NN
        results_NNS for_IN the_DT immunohistochemical_JJ detection_NN of_IN BrdU_NNP
        incorporation_NN in_IN cartilage_NN structures_NNS (_( Panels_NNP A_DT ,_, D_NNP )_) ._. To_TO
        directly_RB compare_VB cell_NN proliferation_NN between_IN embryos_NNS of_IN
        different_JJ genotype_NN ,_, sections_NNS of_IN vertebral_NN centers_NNS were_VBD
        assessed_VBN for_IN BrdU_NNP incorporation_NN ._. Figure_NN 4_CD ,_, Panel_NNP E_NNP shows_VBZ
        results_NNS from_IN embryos_NNS isolated_VBN at_IN day_NN 15_CD ._. 75_CD post_NN coitum_NN ._. The_DT
        differences_NNS in_IN cell_NN number_NN /_NN section_NN of_IN vertebral_NN center_NN
        indicate_VBP that_IN individual_JJ embryos_NNS were_VBD more_JJR progressed_VBD in_IN
        overall_JJ growth_NN than_IN others_NNS ,_, and_CC thus_RB had_VBD larger_JJR vertebral_NN
        centers_NNS with_IN more_JJR cells_NNS overall_JJ ._. Maturation_NNP was_VBD consistent_JJ
        within_IN a_DT given_VBN litter_NN (_( compare_VB samples_NNS 1_CD ,_, 2_CD ,_, to_TO 7_CD ,_, 8_CD and_CC 5_CD ,_,
        6_CD to_TO 11_CD ,_, 12_CD ,_, respectively_RB )_) ._. The_DT fraction_NN of_IN cells_NNS positive_JJ
        for_IN BrdU_NNP incorporation_NN was_VBD between_IN 7_CD ._. 8_CD and_CC 14_CD ._. 4_LS %_NN ,_, with_IN a_DT
        trend_NN towards_IN lower_JJR rates_NNS of_IN incorporation_NN in_IN
        developmentally_RB older_JJR embryos_NNS with_IN higher_JJR Hoxc-_NNP 8_CD transgene_NN
        expression_NN levels_NNS (_( TA_NNP /_NN TA_NNP TR_NNP /_NN +_NN ;_: Figure_NN 4_CD ,_, Panel_NNP F_NNP )_) ._. While_IN
        additional_JJ measurements_NNS at_IN later_JJ stages_VBZ of_IN development_NN
        would_MD be_VB needed_VBN to_TO confirm_VB whether_IN this_DT is_VBZ a_DT continuous_JJ
        trend_NN for_IN cartilage_NN development_NN in_IN late_JJ pregnancy_NN in_IN Hoxc-_NNP 8_CD
        overexpressing_VBG animals_NNS ,_, these_DT results_NNS were_VBD initially_RB
        unexpected_JJ :_: The_DT phenotype_NN of_IN Hoxc-_NNP 8_CD transgenic_JJ animals_NNS at_IN
        17_CD ._. 5_LS days_NNS (_( approximately_RB 2_CD days_NNS later_RBR than_IN assayed_JJ here_RB )_) is_VBZ
        characterized_VBN by_IN accumulation_NN of_IN proliferating_VBG cells_NNS ._.
        Intuitively_NNP ,_, the_DT expectation_NN would_MD be_VB that_IN greater_JJR rates_NNS of_IN
        BrdU_NNP incorporation_NN should_MD be_VB found_VBN ._. However_RB ,_, accumulation_NN
        of_IN proliferating_VBG cells_NNS can_MD also_RB result_VB from_IN a_DT slow-down_JJ of_IN
        the_DT cell_NN cycle_NN ,_, in_IN form_NN of_IN a_DT lower_JJR rate_NN of_IN BrdU_NNP
        incorporation_NN ._. It_PRP is_VBZ intriguing_JJ to_TO note_VB that_WDT reduced_VBD BrdU_NNP
        incorporation_NN is_VBZ particularly_RB detected_VBN in_IN developmentally_RB
        older_JJR animals_NNS where_WRB the_DT vertebral_NN centers_NNS are_VBP made_VBN up_RP of_IN a_DT
        larger_JJR number_NN of_IN cells_NNS ,_, reflecting_VBG a_DT longer_JJR duration_NN since_IN
        commitment_NN of_IN the_DT precursors_NNS to_TO chondrocyte_NN fate_NN ._. It_PRP should_MD
        also_RB be_VB noted_VBN that_IN both_DT genotypes_NNS assayed_JJ here_RB develop_VB
        cartilage_NN defects_NNS ,_, which_WDT may_MD explain_VB the_DT relatively_RB
        moderate_JJ differences_NNS ._. A_DT prediction_NN from_IN these_DT data_NNS is_VBZ that_IN
        on_IN subsequent_JJ days_NNS ,_, or_CC upon_IN longer_JJR labeling_VBG intervals_NNS ,_, even_RB
        lower_JJR rates_NNS of_IN BrdU_NNP incorporation_NN should_MD be_VB detected_VBN ._.
        Quantification_NNP of_IN such_JJ findings_NNS ,_, and_CC 
        in_IN vivo_NN measurements_NNS of_IN cell_NN cycle_NN
        duration_NN ,_, however_RB ,_, require_VB pulse-chase_JJ experiments_NNS [_NN 18_CD 19_CD
        ]_NN ,_, which_WDT involve_VBP large_JJ numbers_NNS of_IN animals_NNS and_CC are_VBP very_RB
        time-consuming_JJ ._.
        Instead_RB ,_, we_PRP sought_VBD to_TO investigate_VB the_DT proliferative_JJ
        capacity_NN of_IN chondrocytes_NNS from_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS by_IN
        using_VBG 
        in_IN vitro_NN assays_NNS ._. We_PRP performed_VBD cell_NN
        cycle_NN assays_NNS on_IN primary_JJ chondrocytes_NNS isolated_VBN from_IN rib_NN
        cages_NNS of_IN transgenic_JJ and_CC control_NN neonates_NNS ._. Chondrocytes_NNP were_VBD
        placed_VBN into_IN high_JJ density_NN bulk_NN cultures_NNS [_NN 20_CD ]_NN ,_, where_WRB they_PRP
        initially_RB continued_VBD to_TO proliferate_VBP ,_, and_CC later_RB
        differentiated_JJ ,_, with_IN cartilage_NN nodules_NNS present_JJ by_IN 14_CD days_NNS
        after_IN plating_VBG ._. Figure_NN 5_CD shows_VBZ representative_NN cultures_NNS
        (_( Figure_NN 5_CD ,_, Panels_NNP A-C_NNP )_) ,_, and_CC the_DT growth_NN curve_NN for_IN rib_NN
        chondrocytes_NNS in_IN high_JJ density_NN bulk_NN cultures_NNS (_( Figure_NN 5_CD ,_, Panel_NNP
        D_NNP )_) ._. From_IN this_DT ,_, we_PRP were_VBD able_JJ to_TO estimate_VB a_DT mean_NN doubling_VBG
        time_NN of_IN 17_CD -_: 19_CD hours_NNS ._. This_DT conforms_VBZ well_RB to_TO previous_JJ
        published_VBN measurements_NNS for_IN chick_NN limb_NN chondrocytes_NNS [_NN 21_CD ]_NN
        and_CC rat_NN chondrocytes_NNS 
        in_IN vitro_NN [_NN 22_CD ]_NN ._. The_DT linear_JJ phase_NN of_IN
        growth_NN was_VBD observed_VBN between_IN days_NNS 3_CD and_CC 4_CD ,_, and_CC therefore_RB the_DT
        72_CD hour_NN time_NN point_NN was_VBD chosen_VBN for_IN analysis_NN of_IN cell_NN cycle_NN
        kinetics_NNS of_IN Hoxc-_NNP 8_CD transgenic_JJ chondrocytes_NNS 
        in_IN vitro_NN ._. First_CD ,_, we_PRP established_VBD the_DT
        Fluorescence_NNP Activated_NNP Cell_NNP Sorting_VBG (_( FACS_NNP )_) assay_NN using_VBG
        mouse_NN embryonic_JJ fibroblasts_NNS ,_, and_CC then_RB we_PRP assayed_JJ rib_NN
        chondrocytes_NNS from_IN Hoxc-_NNP 8_CD transgenic_JJ and_CC control_NN mice_NNS in_IN
        high_JJ density_NN bulk_NN cultures_NNS ._. From_IN these_DT cultures_NNS ,_, cells_NNS were_VBD
        removed_VBN at_IN various_JJ timepoints_NNS after_IN BrdU_NNP incorporation_NN and_CC
        subjected_VBN to_TO Flow_NNP cytometry_NN ._. Figure_NN 6_CD (_( Panels_NNP A-E_NNP "_'' )_) shows_VBZ a_DT
        typical_JJ result_NN for_IN fibroblasts_NNS ._. The_DT same_JJ readout_NN was_VBD used_VBN
        for_IN cultures_NNS of_IN primary_JJ rib_NN chondrocytes_NNS (_( Figure_NN 6_CD ,_, Panels_NNP
        F-O_NNP )_) ._. As_IN cells_NNS go_VBP through_IN the_DT cell_NN cycle_NN ,_, DNA_NNP content_NN
        increases_NNS ,_, and_CC this_DT is_VBZ reflected_VBN in_IN a_DT concomitant_NN increase_NN
        in_IN BrdU_NNP incorporation_NN ._. Upon_IN division_NN ,_, the_DT signal_NN for_IN DNA_NNP
        content_NN is_VBZ reduced_VBN by_IN half_NN ,_, while_IN overall_JJ BrdU_NNP
        incorporation_NN increases_NNS with_IN every_DT subsequent_JJ cell_NN cycle_NN ._.
        These_DT assays_NNS allowed_VBD us_PRP to_TO determine_VB the_DT fraction_NN of_IN cells_NNS
        in_IN each_DT stage_NN of_IN the_DT cell_NN cycle_NN (_( Figure_NN 7_CD ,_, Panel_NNP A_DT )_) ,_, and_CC
        established_VBD FACS_NNP analysis_NN as_IN a_DT valuable_JJ tool_NN for_IN the_DT
        analysis_NN of_IN chondrocyte_NN proliferation_NN ._.
        Interestingly_RB ,_, when_WRB primary_JJ chondrocytes_NNS from_IN Hoxc-_NNP 8_CD
        transgenic_JJ mice_NNS were_VBD assayed_JJ ,_, they_PRP showed_VBD the_DT same_JJ cell_NN
        cycle_NN kinetics_NNS as_IN chondrocytes_NNS from_IN control_NN animals_NNS ._.
        Essentially_RB similar_JJ proportions_NNS of_IN cells_NNS in_IN S_NNP phase_NN were_VBD
        found_VBN in_IN all_DT cultures_NNS (_( Figure_NN 7_CD ,_, Panel_NNP B_NNP )_) ._. This_DT was_VBD
        regardless_RB of_IN levels_NNS of_IN expression_NN of_IN the_DT Hoxc-_NNP 8_CD transgene_NN
        (_( Figure_NN 7_CD ,_, Panel_NNP B_NNP )_) which_WDT increases_NNS with_IN increasing_VBG
        transgene_NN dosage_NN [_NN 1_CD 23_CD ]_NN ._. These_DT data_NNS indicate_VBP that_IN ,_, after_IN
        appropriate_JJ time_NN in_IN culture_NN ,_, transgenic_JJ chondrocytes_NNS were_VBD
        able_JJ to_TO proliferate_VBP normally_RB ,_, at_IN least_JJS over_IN the_DT 24_CD hours_NNS
        duration_NN of_IN the_DT assay_NN ._.
        Given_VBN our_PRP$ inability_NN to_TO distinguish_VB Hoxc-_NNP 8_CD transgenic_JJ
        cells_NNS from_IN controls_NNS by_IN parameters_NNS for_IN either_DT cell_NN
        differentiation_NN or_CC proliferation_NN ,_, we_PRP sought_VBD to_TO determine_VB
        which_WDT molecular_JJ differences_NNS exist_VBP in_IN our_PRP$ transgenic_JJ mice_NNS
        associated_VBN with_IN the_DT documented_VBN deficiencies_NNS in_IN cartilage_NN
        maturation_NN [_NN 1_CD ]_NN ._. To_TO this_DT end_NN ,_, we_PRP analyzed_VBD gene_NN expression_NN
        in_IN freshly_RB isolated_VBN primary_JJ rib_NN chondrocytes_NNS from_IN Hoxc-_NNP 8_CD
        transgenic_JJ animals_NNS [_NN 1_CD ]_NN ._. Real-time_NNP quantitative_JJ PCR_NNP was_VBD
        performed_VBN ._. As_IN shown_VBN in_IN Figure_NN 8_CD ,_, Hoxc-_NNP 8_CD expression_NN is_VBZ
        elevated_VBD in_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS ,_, as_IN expected_VBN [_NN 23_CD ]_NN ._.
        Differences_NNS also_RB exist_VBP between_IN controls_NNS and_CC transgenics_NNS in_IN
        expression_NN levels_NNS for_IN several_JJ genes_NNS involved_VBN in_IN cartilage_NN
        development_NN ._. For_IN example_NN ,_, Collagen_NNP II_NNP expression_NN (_( splice_NN
        form_NN A_DT )_) is_VBZ increased_VBN ,_, as_IN is_VBZ Ihh_NNP mRNA_NN ,_, and_CC Bmp-_NNP 4_CD and_CC p_NN 107_CD
        expression_NN are_VBP decreased_VBN ._. Taken_VBN together_RB ,_, these_DT results_NNS
        establish_VB alterations_NNS in_IN gene_NN expression_NN upon_IN
        overexpression_NN of_IN the_DT Hoxc-_NNP 8_CD transgene_NN in_IN the_DT developing_VBG
        skeleton_NN ._.
        The_DT biological_JJ corollaries_NNS of_IN changes_NNS in_IN gene_NN expression_NN
        profiles_NNS are_VBP noteworthy_JJ in_IN that_IN they_PRP may_MD provide_VB evidence_NN
        on_IN the_DT molecular_JJ targets_NNS of_IN Hox_NNP genes_NNS in_IN cartilage_NN ,_, as_RB well_RB
        as_IN on_IN the_DT consequences_NNS of_IN Hox_NNP gene_NN overexpression_NN ._. In_IN
        Hoxc-_NNP 8_CD transgenic_JJ chondrocytes_NNS ,_, we_PRP found_VBD increased_VBN
        expression_NN of_IN Collagen_NNP II_NNP splice_NN form_NN A_DT mRNA_NN [_NN 24_CD ]_NN ._. This_DT
        is_VBZ consistent_JJ with_IN our_PRP$ earlier_RBR finding_NN of_IN at_IN least_JJS 2_CD -_: fold_VB
        increased_VBN Collagen_NNP II_NNP mRNA_NN expression_NN by_IN in_IN situ_NN
        hybridization_NN and_CC increased_VBN numbers_NNS of_IN immature_NN
        chondrocytes_NNS in_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS [_NN 1_CD ]_NN ._. Sox-_NNP 5_CD ,_, which_WDT
        is_VBZ normally_RB expressed_VBN in_IN proliferating_VBG chondrocytes_NNS [_NN 25_CD 26_CD
        ]_NN ,_, is_VBZ elevated_VBD in_IN Hoxc-_NNP 8_CD transgenic_JJ cells_NNS ,_, again_RB
        consistent_JJ with_IN accumulation_NN of_IN immature_NN chondrocytes_NNS ._.
        Unexpected_NNP was_VBD the_DT elevated_VBD expression_NN of_IN Collagen_NNP X_NNP mRNA_NN ,_,
        a_DT marker_NN for_IN hypertrophic_JJ cells_NNS ._. As_IN fewer_RBR hypertrophic_JJ
        cells_NNS are_VBP present_JJ in_IN Hoxc-_NNP 8_CD transgenics_NNS ,_, and_CC cartilage_NN
        maturation_NN is_VBZ delayed_VBN in_IN Hoxc-_NNP 8_CD transgenic_JJ animals_NNS [_NN 1_CD ]_NN ,_,
        one_PRP would_MD expect_VB to_TO see_VB decreased_VBD Collagen_NNP X_NNP mRNA_NN levels_NNS [_NN
        27_CD ]_NN ._. Yet_RB ,_, the_DT data_NNS clearly_RB indicate_VBP that_DT mRNA_NN expression_NN
        is_VBZ elevated_VBD in_IN transgenic_JJ rib_NN chondrocytes_NNS ._. This_DT could_MD be_VB
        either_CC from_IN increased_VBN Collagen_NNP X_NNP mRNA_NN transcription_NN within_IN
        prehypertrophic_JJ and_CC hypertrophic_JJ cells_NNS or_CC from_IN ectopic_JJ
        activation_NN of_IN Collagen_NNP X_NNP transcription_NN in_IN proliferating_VBG
        chondrocytes_NNS ._. Whether_IN either_DT of_IN these_DT possibilities_NNS would_MD
        also_RB increase_VB Collagen_NNP X_NNP expression_NN at_IN the_DT protein_NN level_NN
        remains_VBZ to_TO be_VB investigated_VBN ._. Interestingly_RB ,_, Collagen_NNP X_NNP
        expression_NN has_VBZ been_VBN shown_VBN to_TO be_VB induced_VBN by_IN Bmp-_NNP 2_CD [_NN 28_CD ]_NN ,_,
        which_WDT is_VBZ overexpressed_JJ in_IN our_PRP$ transgenic_JJ mice_NNS ._. Bmp-_NNP 2_CD
        signaling_VBG has_VBZ a_DT positive_JJ effect_NN on_IN chondrocyte_NN
        proliferation_NN [_NN 29_CD ]_NN ,_, and_CC can_MD induce_VB Indian_JJ hedgehog_NN (_( Ihh_NNP )_)
        expression_NN in_IN responsive_JJ cells_NNS [_NN 30_CD ]_NN ._. We_PRP find_VBP Ihh_NNP mRNA_NN
        elevated_VBD in_IN Hoxc-_NNP 8_CD transgenic_JJ chondrocytes_NNS (_( see_VB Figure_NN 8_CD )_) ._.
        Ihh_NNP can_MD induce_VB Bmp_NNP expression_NN in_IN proliferating_VBG cells_NNS ,_,
        further_JJ increasing_VBG positive_JJ effects_NNS on_IN chondrocyte_NN
        proliferation_NN [_NN 31_CD ]_NN ._. At_IN the_DT same_JJ time_NN ,_, Ihh_NNP decreases_VBZ the_DT
        rate_NN of_IN progression_NN to_TO hypertrophy_NN [_NN 32_CD 33_CD ]_NN ,_, again_RB
        consistent_JJ with_IN an_DT accumulation_NN of_IN proliferating_VBG cells_NNS in_IN
        our_PRP$ transgenic_JJ animals_NNS ._. Whether_IN the_DT elevated_VBD Ihh_NNP mRNA_NN
        levels_NNS originate_VB from_IN increased_VBN expression_NN in_IN cells_NNS that_WDT
        make_VBP Ihh_NNP normally_RB (_( prehypertrophic_JJ and_CC hypertrophic_JJ
        chondrocytes_NNS )_) or_CC from_IN ectopic_JJ activation_NN by_IN the_DT Hox_NNP
        transcription_NN factors_NNS in_IN proliferating_VBG cells_NNS ,_, remains_VBZ to_TO be_VB
        investigated_VBN ._. Greater_NNP numbers_NNS of_IN prehypertrophic_JJ cells_NNS are_VBP
        unlikely_JJ to_TO account_VB for_IN elevated_JJ expression_NN of_IN
        prehypertrophic_JJ cell_NN markers_NNS :_: histological_JJ sections_NNS from_IN
        Hoxc-_NNP 8_CD transgenic_JJ animals_NNS show_VBP no_DT increase_NN in_IN
        prehypertrophic_JJ cells_NNS [_NN 1_CD ]_NN ,_, and_CC PTHrP_NNP receptor_NN mRNA_NN
        levels_NNS are_VBP unchanged_JJ in_IN cells_NNS from_IN transgenic_JJ animals_NNS (_( see_VB
        Figure_NN 8_CD )_) ._. These_DT data_NNS also_RB suggest_VBP that_IN PTHrP_NNP signaling_VBG [_NN
        34_CD 35_CD 36_CD ]_NN is_VBZ only_RB moderately_RB affected_VBN by_IN overexpression_NN of_IN
        Hoxc-_NNP 8_CD ._. We_PRP found_VBD the_DT expression_NN of_IN p_NN 107_CD mRNA_NN and_CC Bmp-_NNP 4_CD mRNA_NN
        to_TO be_VB decreased_VBN ,_, which_WDT ,_, if_IN reflected_VBD in_IN reduced_VBN protein_NN
        levels_NNS ,_, would_MD be_VB consistent_JJ with_IN the_DT phenotype_NN of_IN delayed_VBN
        cartilage_NN maturation_NN in_IN Hox_NNP transgenic_JJ animals_NNS :_: As_IN Bmp-_NNP 4_CD
        was_VBD shown_VBN to_TO have_VB a_DT positive_JJ effect_NN on_IN hypertrophy_NN and_CC
        inhibitory_NN effect_NN on_IN proliferation_NN [_NN 37_CD 38_CD ]_NN ,_, decreased_VBD
        Bmp-_NNP 4_CD expression_NN would_MD be_VB expected_VBN to_TO promote_VB chondrocyte_NN
        proliferation_NN ._. p_NN 107_CD has_VBZ been_VBN shown_VBN to_TO be_VB required_VBN for_IN exit_NN
        from_IN the_DT cell_NN cycle_NN [_NN 39_CD 40_CD ]_NN ,_, and_CC reduced_VBD p_NN 107_CD expression_NN
        is_VBZ associated_VBN with_IN deregulated_VBN proliferation_NN ._. Also_RB ,_,
        chondrocytes_NNS without_IN p_NN 107_CD expression_NN fail_VB to_TO respond_VB to_TO
        inhibitory_NN signals_NNS from_IN FGFs_NNP [_NN 41_CD ]_NN ._. The_DT relationship_NN to_TO
        elevated_VBD Fgf_NNP receptor_NN 3_CD mRNA_NN levels_NNS in_IN Hoxc-_NNP 8_CD transgenic_JJ
        cells_NNS ,_, however_RB ,_, remains_VBZ to_TO be_VB clarified_VBN ._. The_DT same_JJ caveat_NN
        applies_VBZ to_TO elevated_VBD expression_NN in_IN Hoxc-_NNP 8_CD transgenic_JJ cells_NNS
        of_IN p_NN 130_CD ,_, which_WDT is_VBZ also_RB known_VBN to_TO be_VB linked_VBN to_TO cell_NN cycle_NN
        exit_NN and_CC FGF_NNP response_NN [_NN 39_CD ]_NN ._. While_IN the_DT profile_NN of_IN gene_NN
        expression_NN changes_NNS in_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS is_VBZ suggestive_JJ
        of_IN interactions_NNS between_IN the_DT various_JJ gene_NN products_NNS ,_, further_JJ
        studies_NNS will_MD be_VB required_VBN to_TO mechanistically_RB link_VB the_DT gene_NN
        expression_NN differences_NNS to_TO the_DT maturational_NN delay_NN in_IN the_DT
        Hoxc-_NNP 8_CD transgenic_JJ cartilage_NN ._.
        In_IN summary_NN ,_, the_DT gene_NN expression_NN profiles_NNS of_IN primary_JJ
        chondrocytes_NNS from_IN Hoxc-_NNP 8_CD transgenic_JJ animals_NNS display_VBP notable_JJ
        differences_NNS in_IN the_DT expression_NN of_IN regulators_NNS of_IN chondrocyte_NN
        maturation_NN in_IN a_DT pattern_NN largely_RB consistent_JJ with_IN delayed_VBN
        chondrocyte_NN maturation_NN 
        in_IN vivo_NN ._. These_DT results_NNS now_RB allow_VBP us_PRP
        to_TO investigate_VB whether_IN any_DT of_IN these_DT molecules_NNS is_VBZ directly_RB
        regulated_VBN by_IN Hox_NNP transcription_NN factors_NNS in_IN chondrocytes_NNS ._. It_PRP
        is_VBZ also_RB remarkable_JJ ,_, as_IN apparent_JJ from_IN our_PRP$ cell_NN culture_NN
        results_NNS ,_, that_IN cells_NNS with_IN obvious_JJ molecular_JJ differences_NNS
        downstream_JJ of_IN Hoxc-_NNP 8_CD expression_NN can_MD be_VB modulated_JJ to_TO
        resemble_VB a_DT normal_JJ chondrocyte_NN phenotype_NN after_IN a_DT few_JJ days_NNS in_IN
        culture_NN ._.
      
      
        Discussion_NNP
        Our_PRP$ studies_NNS of_IN chondrocytes_NNS from_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS
        reveal_VBP several_JJ interesting_JJ results_NNS :_: 
        in_IN vivo_NN ,_, chondrocytes_NNS remain_VBP
        relatively_RB immature_NN ,_, with_IN few_JJ progressing_VBG to_TO hypertrophy_NN in_IN
        Hoxc-_NNP 8_CD transgenic_JJ mice_NNS ._. Combined_VBN with_IN the_DT fact_NN that_IN some_DT ,_,
        albeit_IN fewer_JJR ,_, hypertrophic_JJ cells_NNS are_VBP present_JJ ,_, the_DT
        accumulation_NN of_IN proliferating_VBG chondrocytes_NNS suggests_VBZ that_IN
        Hoxc-_NNP 8_CD regulates_VBZ the_DT rate_NN of_IN progression_NN of_IN chondrocytes_NNS to_TO
        maturity_NN [_NN 1_CD ]_NN ._. In_IN line_NN with_IN this_DT interpretation_NN ,_, the_DT 
        in_IN vivo_NN BrdU_NNP incorporation_NN assays_NNS
        suggested_VBD that_DT cell_NN cycle_NN progression_NN of_IN chondrocytes_NNS may_MD
        be_VB decreased_VBN in_IN transgenic_JJ animals_NNS with_IN higher_JJR Hoxc-_NNP 8_CD
        transgene_NN expression_NN levels_NNS ._. If_IN fewer_JJR immature_NN cells_NNS enter_VBP
        the_DT cell_NN cycle_NN in_IN a_DT given_VBN time_NN interval_NN ,_, this_DT is_VBZ consistent_JJ
        with_IN ,_, and_CC would_MD explain_VB the_DT increased_VBN steady-state_JJ numbers_NNS
        of_IN chondrocytes_NNS upon_IN Hoxc-_NNP 8_CD overexpression_NN ._. This_DT could_MD
        occur_VB through_IN two_CD different_JJ mechanisms_NNS :_: (_( 
        i_NNP )_) Hoxc-_NNP 8_CD actively_RB recruits_VBZ cells_NNS into_IN
        the_DT chondrocyte_NN lineage_NN and_CC maintains_VBZ them_PRP in_IN the_DT
        proliferating_VBG state_NN ;_: or_CC (_( 
        ii_NN )_) Hoxc-_NNP 8_CD inhibits_NNS a_DT specific_JJ step_NN in_IN
        chondrocyte_NN maturation_NN ._. In_IN order_NN to_TO distinguish_VB between_IN
        these_DT possibilities_NNS ,_, we_PRP sought_VBD to_TO employ_VB cell_NN culture_NN
        assays_NNS with_IN well-established_JJ parameters_NNS for_IN chondrocyte_NN
        differentiation_NN and_CC maturation_NN ._. Interestingly_RB ,_, chondrocytes_NNS
        from_IN Hoxc-_NNP 8_CD tansgenic_JJ animals_NNS behaved_VBD undistinguishable_JJ
        from_IN control_NN cells_NNS under_IN all_DT conditions_NNS tested_VBN ._. No_DT
        differences_NNS were_VBD found_VBN in_IN capacity_NN to_TO differentiate_VB in_IN
        micromass_NNS (_( see_VB Figure_NN 3_LS )_) ,_, or_CC in_IN high_JJ density_NN cultures_NNS (_( not_RB
        shown_VBN )_) ,_, and_CC proliferative_JJ indices_NNS are_VBP comparable_JJ (_( see_VB
        Figure_NN 7_CD )_) ,_, irrespective_RB of_IN transgene_NN dosage_NN ._. The_DT latter_NN
        could_MD be_VB explained_VBN by_IN the_DT fact_NN that_IN the_DT FACS_NNP analyses_NNS were_VBD
        done_VBN at_IN the_DT time_NN of_IN greatest_JJS proliferation_NN ,_, three_CD days_NNS
        after_IN culture_NN initiation_NN ,_, which_WDT may_MD allow_VB transgenic_JJ cells_NNS
        to_TO recover_VB to_TO a_DT normal_JJ phenotype_NN ._. However_RB ,_, we_PRP did_VBD not_RB
        detect_VB any_DT differences_NNS in_IN the_DT first_JJ few_JJ days_NNS of_IN culture_NN by_IN
        microscopy_NN or_CC histology_NN ._. Cellular_NNP differences_NNS must_MD exist_VB at_IN
        the_DT time_NN the_DT cells_NNS are_VBP taken_VBN from_IN the_DT animal_NN (_( which_WDT would_MD
        be_VB expected_VBN to_TO die_VB as_IN a_DT Hoxc-_NNP 8_CD transgenic_JJ )_) ,_, and_CC indeed_RB
        molecular_JJ differences_NNS exist_VBP (_( see_VB Figure_NN 8_CD )_) ._. Yet_RB ,_, the_DT cell_NN
        culture_NN conditions_NNS either_CC quickly_RB reverse_VB cellular_JJ
        phenotype_NN or_CC support_VB normal_JJ chondrocyte_NN maturation_NN ._.
        Alternatively_RB ,_, it_PRP is_VBZ conceivable_JJ that_IN the_DT Hoxc-_NNP 8_CD transgene_NN
        could_MD be_VB silenced_VBN as_IN cells_NNS are_VBP isolated_VBN from_IN the_DT animal_NN ,_,
        returning_VBG cells_NNS to_TO their_PRP$ normal_JJ phenotype_NN ._. There_EX is_VBZ little_JJ
        evidence_NN to_TO support_VB this_DT possibility_NN as_IN Hoxc-_NNP 8_CD is_VBZ expressed_VBN
        normally_RB in_IN our_PRP$ chondrocyte_NN cultures_NNS (_( data_NNS not_RB shown_VBN )_) ,_, and_CC
        the_DT promoter_NN used_VBN to_TO drive_VB the_DT transgene_NN contains_VBZ a_DT
        cartilage-specific_JJ element_NN (_( Cormier_NNP and_CC Kappen_NNP ,_, unpublished_JJ
        results_NNS )_) that_WDT is_VBZ active_JJ in_IN chondrocytes_NNS ._. Yet_RB ,_, even_RB if_IN
        transgene_NN expression_NN was_VBD reduced_VBN in_IN culture_NN ,_, the_DT important_JJ
        implication_NN of_IN our_PRP$ results_NNS is_VBZ that_IN the_DT downstream_JJ
        biological_JJ effects_NNS of_IN at_IN least_JJS 6_CD days_NNS of_IN Hoxc-_NNP 8_CD
        overexpression_NN 
        in_IN vivo_NN are_VBP reversible_JJ ._. From_IN these_DT
        results_NNS ,_, we_PRP postulate_NN that_IN the_DT cartilage_NN defect_NN in_IN Hoxc-_NNP 8_CD
        transgenic_JJ mice_NNS is_VBZ mediated_JJ by_IN absence_NN of_IN factors_NNS /_NN signals_NNS
        that_WDT are_VBP present_JJ in_IN the_DT culture_NN medium_NN ._. Serum-free_NNP
        conditions_NNS and_CC supplementation_NN with_IN candidate_NN molecules_NNS
        would_MD be_VB one_CD strategy_NN to_TO investigate_VB this_DT further_RB ._. An_DT
        interesting_JJ ,_, albeit_IN preliminary_JJ ,_, finding_VBG from_IN our_PRP$ gene_NN
        expression_NN studies_NNS is_VBZ that_IN chondrocytes_NNS from_IN Hoxc-_NNP 8_CD
        transgenic_JJ animals_NNS display_VBP gene_NN expression_NN profiles_NNS that_WDT
        are_VBP indicative_JJ for_IN immature_NN chondrocytes_NNS ,_, but_CC not_RB totally_RB
        identical_JJ ._. This_DT suggests_VBZ that_IN both_DT Hox_NNP transcription_NN
        factors_NNS may_MD ,_, in_IN addition_NN to_TO the_DT delay_NN in_IN chondrocyte_NN
        maturation_NN ,_, induce_VB specific_JJ changes_NNS in_IN gene_NN expression_NN ._. By_IN
        extending_VBG the_DT collection_NN of_IN candidate_NN genes_NNS ,_, or_CC screening_NN
        on_IN microarrays_NNS ,_, it_PRP may_MD thus_RB be_VB possible_JJ to_TO identify_VB
        specific_JJ targets_NNS for_IN Hox_NNP transcription_NN factors_NNS in_IN
        chondrocytes_NNS ._.
      
      
        Conclusions_NNP
        Our_PRP$ results_NNS support_VBP the_DT conclusion_NN that_IN factors_NNS in_IN
        serum-containing_JJ medium_NN provide_VBP the_DT environment_NN in_IN which_WDT
        Hoxc-_NNP 8_CD transgenic_JJ chondrocytes_NNS are_VBP capable_JJ of_IN reverting_VBG to_TO
        a_DT normal_JJ cellular_JJ phenotype_NN ._. Thus_RB ,_, Hoxc-_NNP 8_CD induced_VBN changes_NNS
        in_IN chondrocytes_NNS are_VBP reversible_JJ under_IN certain_JJ conditions_NNS ._.
        This_DT has_VBZ important_JJ implications_NNS for_IN the_DT identification_NN of_IN
        the_DT transcriptional_NN targets_NNS of_IN Hox_NNP transcription_NN factors_NNS ._.
        In_IN our_PRP$ system_NN ,_, the_DT biological_JJ effects_NNS of_IN Hox_NNP genes_NNS in_IN
        chondrocytes_NNS can_MD be_VB modulated_JJ by_IN external_JJ factors_NNS ,_, and_CC this_DT
        finding_VBG points_NNS to_TO the_DT importance_NN of_IN gene-environment_JJ
        interactions_NNS as_IN modulators_NNS of_IN Hox_NNP gene_NN function_NN ._.
      
      
        Methods_NNP
        
          Preparation_NNP of_IN mouse_NN rib_NN chondrocytes_NNS
          The_DT preparation_NN of_IN primary_JJ rib_NN chondrocytes_NNS from_IN
          neonatal_NN mice_NNS is_VBZ a_DT modification_NN of_IN the_DT method_NN used_VBN by_IN
          Lefebvre_NNP et_CC al_NN ._. [_NN 20_CD ]_NN ._. Briefly_NNP ,_, newborn_JJ FVB_NNP mice_NNS were_VBD
          sacrificed_JJ ,_, and_CC the_DT ventral_NN regions_NNS of_IN rib_NN cages_NNS were_VBD
          dissected_VBN in_IN sterile_JJ conditions_NNS to_TO release_VB soft_JJ tissues_NNS ._.
          Rib_NNP cages_NNS were_VBD transferred_VBN to_TO phosphate_NN buffered_JJ saline_NN
          (_( PBS_NNP )_) and_CC washed_VBN extensively_RB ._. Cells_NNP were_VBD dissociated_JJ in_IN
          50_CD ml_NN tubes_NNS by_IN enzymatic_JJ digestion_NN with_IN 0_CD ._. 25_CD %_NN Collagenase_NNP
          (_( Worthington_NNP Biochemical_NNP ,_, Collagenase_NNP Type_NNP 2_CD -_: CLS_NNP 2_LS )_) and_CC
          0_CD ._. 25_CD %_NN Trypsin_NNP /_NN EDTA_NNP (_( Invitrogen_NNP /_NN Gibco_NNP BRL_NNP )_) for_IN 1_CD hour_NN at_IN
          37_CD °_NN C_NNP ,_, or_CC until_IN the_DT soft_JJ tissues_NNS were_VBD floating_VBG in_IN the_DT
          solution_NN ._. The_DT solution_NN was_VBD aspirated_JJ ,_, leaving_VBG the_DT rib_NN
          cages_NNS on_IN the_DT bottom_NN of_IN the_DT tube_NN ._. The_DT ribcages_NNS were_VBD washed_VBN
          with_IN PBS_NNP ,_, and_CC fresh_JJ 0_CD ._. 25_CD %_NN Collagenase_NNP in_IN PBS_NNP was_VBD added_VBN
          for_IN 1_CD hour_NN at_IN 37_CD °_NN C_NNP ,_, or_CC until_IN the_DT rib_NN cages_NNS were_VBD
          dissociated_JJ ._. The_DT enzymatic_JJ reaction_NN was_VBD stopped_VBN with_IN an_DT
          equal_JJ volume_NN of_IN tissue_NN culture_NN medium_NN containing_VBG 10_CD %_NN FCS_NNP ._.
          The_DT cells_NNS were_VBD filtered_VBN through_IN a_DT 70_CD μm_NN cell_NN strainer_NN
          (_( Becton_NNP Dickinson_NNP )_) and_CC pelleted_JJ by_IN centrifugation_NN in_IN 50_CD
          ml_NN conical_JJ tubes_NNS (_( maximum_NN volume_NN 25_CD ml_NN )_) at_IN 1200_CD rpm_NN for_IN 5_CD
          minutes_NNS ._. The_DT pellet_NN was_VBD washed_VBN with_IN PBS_NNP ,_, cells_NNS were_VBD
          counted_VBN ,_, and_CC adjusted_VBD for_IN desired_VBN cell_NN density_NN ._.
        
        
          Primary_JJ chondrocyte_NN high_JJ density_NN bulk_NN
          cultures_NNS
          For_IN analysis_NN of_IN cell_NN cycle_NN parameters_NNS ,_, we_PRP kept_VBD primary_JJ
          chondrocytes_NNS in_IN high_JJ density_NN bulk_NN cultures_NNS ,_, as_IN this_DT
          allows_VBZ for_IN recovery_NN of_IN cells_NNS for_IN flow_NN cytometry_NN ._. These_DT
          cultures_NNS undergo_VBP chondrocyte_NN maturation_NN with_IN
          differentiation_NN to_TO hypertrophy_NN and_CC formation_NN of_IN cartilage_NN
          modules_NNS ._. Briefly_NNP ,_, cells_NNS were_VBD plated_JJ on_IN 35_CD mm_NN dishes_NNS
          coated_VBN with_IN 0_CD ._. 1_CD %_NN gelatin_NN at_IN a_DT final_JJ concentration_NN of_IN 3_CD ×_NN
          10_CD 5_CD /_NN dish_NN ,_, in_IN DMEM_NNP ,_, high_JJ glucose_NN ,_, 10_CD %_NN FCS_NNP and_CC 25_CD μg_NN /_NN ml_NN
          L-_NNP ascorbic_JJ acid_NN ._. Removal_NNP of_IN cells_NNS was_VBD done_VBN by_IN
          trypsinization_NN ._. For_IN Alcian_NNP Blue_NNP staining_VBG ,_, cells_NNS were_VBD
          fixed_VBN in_IN 70_CD %_NN Ethanol_NNP for_IN 30_CD minutes_NNS and_CC then_RB incubated_JJ
          for_IN one_CD hour_NN with_IN the_DT Alcian_NNP Blue_NNP staining_VBG solution_NN ,_,
          which_WDT consisted_VBD of_IN 15_CD mg_NN Alcian_NNP Blue_NNP 8_CD GX_NNP (_( Sigma_NNP )_) in_IN 30_CD ml_NN
          of_IN 95_CD %_NN Ethanol_NNP and_CC 20_CD ml_NN Glacial_NNP acetic_JJ acid_NN ._. Cells_NNP were_VBD
          rinsed_JJ again_RB with_IN 70_CD %_NN Ethanol_NNP ,_, and_CC dehydrated_JJ through_IN an_DT
          Ethanol_NNP series_NN before_IN coverslipping_VBG on_IN the_DT dish_NN ._.
        
        
          Primary_JJ high_JJ density_NN micromass_NNS cultures_NNS
          For_IN micromass_NNS cultures_NNS [_NN 12_CD ]_NN ,_, cell_NN density_NN was_VBD
          adjusted_VBN to_TO 25_CD ×_NN 10_CD 6_CD cells_NNS /_NN ml_NN ._. 103_CD l_NN of_IN cell_NN suspension_NN
          was_VBD plated_JJ in_IN the_DT center_NN of_IN a_DT culture_NN well_RB (_( 24_CD -_: well_RB
          plate_NN ,_, Midwest_NNP Scientific_NNP )_) ._. The_DT cultures_NNS were_VBD incubated_JJ
          at_IN 37_CD °_NN C_NNP in_IN a_DT humidified_JJ incubator_NN with_IN 5_CD %_NN CO_NNP 
          2_CD for_IN 1_CD 1_CD /_NN 2_CD to_TO 2_CD hours_NNS to_TO allow_VB for_IN
          cell_NN adhesion_NN and_CC attachment_NN ._. Medium_NNP was_VBD added_VBN very_RB
          slowly_RB and_CC consisted_VBD of_IN a_DT 1_CD :_: 1_CD mixture_NN of_IN DMEM_NNP and_CC F_NN 12_CD
          (_( Life_NNP Technologies_NNPS /_NN Gibco_NNP BRL_NNP )_) supplemented_JJ with_IN 10_CD %_NN fetal_JJ
          calf_NN serum_NN (_( Hyclone_NNP )_) ,_, 5000_CD U_NNP /_NN ml_NN Penicillin_NNP ,_, 53_CD g_SYM /_NN ml_NN
          Streptomycin_NNP (_( Life_NNP Technologies_NNPS /_NN Gibco_NNP BRL_NNP )_) ,_, 25_CD μg_NN /_NN ml_NN
          L-_NNP ascorbic_JJ acid_NN (_( Life_NNP Technologies_NNPS /_NN Gibco_NNP BRL_NNP )_) and_CC 10_CD mM_NN
          β-_NN Glycerophosphate_NNP (_( Sigma_NNP )_) ._. Medium_NNP was_VBD replaced_VBN with_IN
          fresh_JJ medium_NN every_DT other_JJ day_NN [_NN 11_CD 13_CD 42_CD ]_NN ._.
        
        
          Assessment_NNP of_IN morphological_JJ and_CC histological_JJ
          parameters_NNS of_IN micromass_NNS cultured_JJ cells_NNS
          During_IN the_DT first_JJ 2_CD or_CC 3_CD days_NNS ,_, micromass_NNS cultures_NNS were_VBD
          observed_VBN directly_RB by_IN phase_NN contrast_NN light_JJ microscopy_NN ._.
          After_IN that_DT ,_, cultures_NNS were_VBD harvested_VBN ,_, washed_VBN in_IN PBS_NNP ,_, fixed_VBN
          in_IN 4_CD %_NN Paraformaldehyde_NNP for_IN 45_CD minutes_NNS ,_, dehydrated_JJ in_IN
          graded_JJ series_NN of_IN Ethanol_NNP and_CC paraffin-embedded_JJ for_IN
          subsequent_JJ analysis_NN ._. We_PRP used_VBD histochemical_JJ staining_VBG with_IN
          Hematoxylin_NNP and_CC Eosin_NNP to_TO ascertain_VB cell_NN morphology_NN ;_: and_CC
          Alcian_NNP Blue_NNP at_IN pH_NN 1_CD [_NN 43_CD ]_NN to_TO detect_VB cartilage_NN matrix_NN
          sulfated_JJ glucosaminoglycans_NNS as_IN described_VBN before_IN [_NN 1_CD ]_NN ._.
          The_DT production_NN of_IN Collagen_NNP type_NN II_NNP was_VBD assessed_VBN by_IN
          immunohistochemistry_NN using_VBG a_DT monoclonal_NN antibody_NN against_IN
          mouse_NN type_NN II_NNP Collagen_NNP (_( Chemicon_NNP )_) ,_, and_CC secondary_JJ antibody_NN
          and_CC colorimetric_JJ reaction_NN kit_NN (_( Histostain_NNP Plus_NNP ,_, Zymed_NNP )_) ._.
          Cell_NNP proliferation_NN was_VBD assessed_VBN by_IN BrdU_NNP incorporation_NN ._.
          Cells_NNP were_VBD incubated_JJ with_IN 3_CD mM_NN of_IN BrdU_NNP (_( Sigma_NNP )_) ,_, harvested_VBN
          after_IN 24_CD hrs_NNS and_CC paraffin-embedded_JJ ._. Cells_NNP with_IN BrdU_NNP
          incorporation_NN were_VBD detected_VBN by_IN immunohistochemistry_NN with_IN
          a_DT monoclonal_NN antibody_NN against_IN BrdU_NNP (_( BrdU_NNP staining_VBG kit_NN ,_,
          Zymed_NNP )_) ._. Cell_NNP size_NN was_VBD determined_VBN by_IN measuring_VBG cell_NN
          diameter_NN microscopically_RB ,_, and_CC mean_VB cell_NN size_NN was_VBD
          calculated_VBN ._. Alkaline_NNP phosphatase_NN activity_NN was_VBD measured_VBN as_IN
          follows_VBZ :_: Cells_NNP were_VBD rinsed_JJ in_IN cold_JJ TBS_NNP (_( Tris-buffered_NNP
          Saline_NNP )_) ,_, scrapped_VBN from_IN the_DT plate_NN ,_, homogenized_JJ in_IN 0_CD ._. 05_CD %_NN
          Triton_NNP X-_NNP 100_CD in_IN Tris-_NNP HCl_NNP (_( pH_NN 7_CD ._. 5_LS )_) on_IN ice_NN ,_, and_CC the_DT sample_NN
          was_VBD centrifuged_JJ at_IN 1200_CD rpm_NN for_IN 5_CD minutes_NNS at_IN 4_CD °_NN C_NNP ._. Protein_NNP
          concentration_NN in_IN the_DT supernatant_NN was_VBD assessed_VBN by_IN Micro_NNP
          BCA_NNP assay_NN (_( Pierce_NNP Chemicals_NNPS )_) ._. Alkaline_NNP phosphatase_NN
          activity_NN in_IN the_DT supernatant_NN was_VBD determined_VBN
          spectrophotometrically_RB at_IN 405_CD nm_NN wavelength_NN as_IN the_DT amount_NN
          of_IN p-nitrophenol_JJ released_VBN from_IN the_DT substrate_NN
          p-nitrophenyl_JJ phosphate_NN (_( ALP_NNP 10_CD ,_, Sigma_NNP )_) ._. Type_NNP X_NNP Collagen_NNP
          deposition_NN in_IN extracellular_NN matrix_NN was_VBD analyzed_VBN by_IN
          immunohistchemistry_NN using_VBG a_DT monoclonal_NN antibody_NN against_IN
          mouse_NN type_NN X_NNP Collagen_NNP (_( Research_NNP Diagnostics_NNPS ,_, Inc_NNP ._. )_) and_CC
          the_DT same_JJ secondary_JJ reagents_NNS as_IN described_VBN above_IN ._. Apoptosis_NNP
          was_VBD assessed_VBN by_IN terminal_NN deoxynucleotidyl_NN
          transferase-mediated_JJ deoxyuridine_NN triphosphate_NN (_( dUTP_NN )_)
          nick_NN end_NN labeling_VBG (_( TUNEL_NNP )_) (_( In_IN situ_NN Cell_NNP Death_NNP Detection_NNP
          Kit_NNP ,_, POD_NNP ,_, Boehringer-_NNP Manheim_NNP )_) ._.
        
        
          Transgenic_NNP mice_NNS
          The_DT generation_NN of_IN Hoxc-_NNP 8_CD transgenic_JJ mice_NNS and_CC the_DT
          characterization_NN of_IN their_PRP$ phenotype_NN have_VBP been_VBN published_VBN [_NN
          1_CD ]_NN ._. Briefly_NNP ,_, Hoxc-_NNP 8_CD expressing_VBG mice_NNS are_VBP generated_VBN in_IN a_DT
          binary_JJ transgenic_JJ mouse_NN system_NN [_NN 44_CD ]_NN by_IN crossing_VBG a_DT
          transactivator_NN strain_NN (_( harboring_VBG a_DT transgene_NN in_IN which_WDT
          expression_NN of_IN the_DT transcriptional_NN transactivator_NN VP_NNP 16_CD is_VBZ
          under_IN control_NN of_IN the_DT Hoxc-_NNP 8_CD promoter_NN ;_: [_NN 45_CD ]_NN )_) to_TO a_DT
          transresponder_NN strain_NN (_( that_WDT carries_VBZ as_IN a_DT transgene_NN the_DT
          Hoxc-_NNP 8_CD cDNA_NN linked_VBN to_TO the_DT ICP_NNP 4_CD immediate_JJ early_JJ gene_NN
          promoter_NN ,_, which_WDT is_VBZ silent_JJ in_IN mice_NNS in_IN the_DT absence_NN of_IN VP_NNP 16_CD ;_:
          [_NN 45_CD 46_CD ]_NN )_) ._. Upon_IN combination_NN of_IN both_DT transgenes_NNS ,_, the_DT
          Hoxc-_NNP 8_CD transresponder_NN transgene_NN is_VBZ activated_VBN ,_, and_CC Hoxc-_NNP 8_CD
          becomes_VBZ overexpressed_JJ [_NN 23_CD ]_NN ._. This_DT system_NN also_RB allows_VBZ
          the_DT generation_NN of_IN transgenic_JJ mice_NNS with_IN increased_VBN gene_NN
          dosage_NN by_IN superimposition_NN of_IN transgene_NN loci_NN to_TO
          homozygosity_NN [_NN 23_CD 44_CD ]_NN ._. For_IN the_DT studies_NNS reported_VBD here_RB ,_,
          we_PRP used_VBD the_DT T_NN 239_CD transactivator_NN and_CC the_DT IE-c_NNP 8_CD -_: 254_CD
          transresponder_NN strains_NNS ._. All_DT procedures_NNS involving_VBG animals_NNS
          were_VBD reviewed_VBN and_CC approved_VBN by_IN the_DT Institutional_NNP Animal_NNP
          Care_NNP and_CC Use_NNP Committee_NNP at_IN UNMC_NNP ._.
          Hoxd-_NNP 4_CD transgenic_JJ mice_NNS were_VBD generated_VBN using_VBG the_DT same_JJ
          transactivator_NN strain_NN crossed_VBN to_TO the_DT IE-d_NNP 4_CD -_: 70_CD
          transresponder_NN strain_NN [_NN 1_CD ]_NN ._. Maintenance_NNP and_CC genotyping_VBG
          of_IN transgenic_JJ mice_NNS was_VBD done_VBN as_IN described_VBN before_IN [_NN 1_CD 23_CD ]_NN
          ._. Unless_IN otherwise_RB noted_VBD ,_, cells_NNS and_CC samples_NNS were_VBD obtained_VBN
          from_IN animals_NNS hemizygous_JJ for_IN both_DT transgenes_NNS ._.
          All_DT transgenes_NNS were_VBD maintained_VBN on_IN a_DT homogenous_JJ FVB_NNP
          inbred_JJ genetic_JJ background_NN ,_, and_CC normal_JJ FVB_NNP mice_NNS were_VBD used_VBN
          as_IN controls_NNS unless_IN mentioned_VBN otherwise_RB ._.
        
        
          In_IN vivo_NN BrdU_NNP incorporation_NN
          To_TO assess_VB chondrocyte_NN proliferation_NN in_IN Hoxc-_NNP 8_CD
          transgenic_JJ mice_NNS ,_, we_PRP performed_VBD 
          in_IN vivo_NN BrdU_NNP labeling_VBG experiments_NNS ._.
          BrdU_NNP labeling_VBG reagent_NN (_( Amersham_NNP RPN_NNP 202_CD )_) in_IN PBS_NNP was_VBD
          injected_VBN into_IN pregnant_JJ females_NNS at_IN 0_CD ._. 01_CD ml_NN /_NN gr_NN body_NN weight_NN ._.
          Four_CD hours_NNS later_RB ,_, dams_NNS were_VBD sacrificed_JJ ,_, embryos_NNS were_VBD
          isolated_VBN and_CC fixed_VBN in_IN 4_CD %_NN paraformaldehyde_NN overnight_JJ at_IN
          4_CD °_NN C_NNP ._. They_PRP were_VBD then_RB dehydrated_JJ through_IN an_DT alcohol_NN series_NN
          and_CC embedded_VBN in_IN paraffin_NN for_IN histological_JJ sectioning_VBG ._.
          Sections_NNP of_IN 10_CD μm_NN thickness_NN were_VBD rehydrated_JJ and_CC incubated_JJ
          for_IN 10_CD minutes_NNS with_IN one_CD part_NN 30_CD %_NN H_NNP 
          2_CD O_NNP 
          2_CD :_: 9_CD parts_NNS MeOH_NNP and_CC processed_VBN in_IN HIER_NNP
          (_( Biotek_NNP Solutions_NNPS )_) ,_, denaturing_VBG and_CC blocking_VBG solutions_NNS
          following_VBG the_DT manufacturer_NN 's_POS protocol_NN ._. Staining_NNP of_IN
          sections_NNS for_IN BrdU_NNP incorporation_NN was_VBD done_VBN using_VBG the_DT Zymed_NNP
          BrdU_NNP staining_VBG kit_NN with_IN Horseradish_NNP Peroxidase_NNP ,_, and_CC
          development_NN with_IN DAB_NNP for_IN 5_CD minutes_NNS ._. Counterstaining_NNP was_VBD
          done_VBN with_IN Hematoxylin_NNP for_IN one_CD minute_NN ._. Sections_NNP of_IN
          vertebral_NN structures_NNS were_VBD matched_VBN between_IN pairs_NNS of_IN
          embryos_NNS from_IN the_DT same_JJ litter_NN according_VBG to_TO anatomical_JJ
          landmarks_NNS of_IN other_JJ tissues_NNS on_IN the_DT same_JJ section_NN ._. Cells_NNP in_IN
          skeletal_NN structures_NNS were_VBD counted_VBN from_IN at_IN least_JJS 5_CD (_( samples_NNS
          1_CD ,_, 2_CD ,_, 7_CD ,_, 8_CD )_) and_CC more_JJR than_IN 10_CD (_( all_DT other_JJ samples_NNS )_) consecutive_JJ
          slides_NNS for_IN each_DT animal_NN and_CC cell_NN counting_VBG was_VBD done_VBN
          independently_RB by_IN two_CD technologists_NNS without_IN knowledge_NN of_IN
          sample_NN genotype_NN ._. Data_NNP were_VBD collected_VBN from_IN three_CD
          independent_JJ experiments_NNS and_CC were_VBD averaged_VBN to_TO
          cells_NNS /_NN section_NN to_TO normalize_VB for_IN potential_JJ growth_NN
          differences_NNS between_IN litters_NNS ._. Exponential_NNP trendlines_NNS were_VBD
          added_VBN by_IN regression_NN analysis_NN as_IN implemented_VBN in_IN Microsoft_NNP
          Excel_NNP ._.
        
        
          Assessment_NNP of_IN cell_NN proliferation_NN in_IN vitro_NN by_IN BrdU_NNP
          incorporation_NN and_CC flow_NN cytometry_NN
          Primary_JJ rib_NN chondrocytes_NNS were_VBD prepared_VBN as_IN described_VBN
          above_IN and_CC 3_CD ×_NN 10_CD 5_CD cells_NNS /_NN well_RB were_VBD placed_VBN into_IN culture_NN in_IN
          6_CD -_: well_RB plates_NNS ._. Medium_NNP was_VBD changed_VBN daily_RB ._. Proliferation_NNP
          was_VBD assessed_VBN by_IN cell_NN counting_NN ,_, and_CC maturation_NN was_VBD
          ascertained_JJ visually_RB as_IN cartilage_NN nodule_NN formation_NN ,_, and_CC
          histochemically_RB by_IN Alcian_NNP Blue_NNP staining_VBG ._. Cell_NNP cycle_NN
          kinetics_NNS were_VBD measured_VBN by_IN BrdU_NNP incorporation_NN and_CC flow_NN
          cytometry_NN for_IN DNA_NNP content_NN at_IN various_JJ time_NN points_NNS after_IN
          initiation_NN of_IN the_DT cultures_NNS ._. Cells_NNP that_WDT had_VBD not_RB been_VBN
          incubated_JJ with_IN any_DT reagents_NNS or_CC cells_NNS that_WDT were_VBD exposed_VBN
          only_RB to_TO anti-_NN BrdU_NNP antibody_NN and_CC Propidium_NNP Iodide_NNP served_VBD as_IN
          controls_NNS ._. For_IN BrdU_NNP incorporation_NN studies_NNS ,_, BrdU_NNP labeling_VBG
          reagent_NN (_( Amersham_NNP )_) was_VBD diluted_VBN 1_CD :_: 1000_CD in_IN medium_NN to_TO a_DT
          final_JJ concentration_NN of_IN 10_CD μM_NN BrdU_NNP and_CC 1_CD μM_NN FdU_NNP ,_, and_CC
          sterilized_VBN through_IN a_DT 0_CD ._. 22_CD μm_NN filter_NN ._. 2_LS ml_NN of_IN staining_VBG
          solution_NN were_VBD added_VBN to_TO each_DT well_RB of_IN a_DT 6_CD -_: well_RB plate_NN ,_,
          followed_VBN by_IN incubation_NN for_IN 0_CD ,_, 6_CD ,_, 12_CD ,_, 18_CD ,_, or_CC 24_CD hours_NNS as_IN
          indicated_VBN ._. To_TO remove_VB the_DT cells_NNS ,_, wells_NNS were_VBD washed_VBN with_IN
          PBS_NNP ,_, and_CC 2_CD ml_NN Trypsin-_NNP EDTA_NNP (_( Gibco_NNP /_NN BRL_NNP )_) was_VBD added_VBN for_IN at_IN
          least_JJS five_CD minutes_NNS at_IN 37_CD °_NN C_NNP ._. The_DT reaction_NN was_VBD inactivated_JJ
          by_IN an_DT equal_JJ volume_NN of_IN serum-containing_JJ medium_NN ,_, and_CC after_IN
          vigorous_JJ pipetting_VBG ,_, cells_NNS were_VBD collected_VBN into_IN Falcon_NNP 2052_CD
          (_( 12_CD ×_NN 75_CD mm_NN ,_, Becton-_NNP Dickinson_NNP )_) tubes_NNS ._. Cells_NNP were_VBD pelleted_JJ
          at_IN 400_CD g_SYM for_IN five_CD minutes_NNS without_IN brakes_NNS ,_, the_DT supernatant_NN
          was_VBD decanted_JJ and_CC the_DT pellet_NN was_VBD loosened_VBN by_IN vortexing_VBG at_IN
          setting_VBG 4_CD ._. Cells_NNP were_VBD washed_VBN with_IN 1_CD %_NN BSA_NNP /_NN PBS_NNP and_CC
          repelleted_JJ ._. During_IN cell_NN resuspension_NN ,_, 1_CD ml_NN ice-cold_JJ 70_CD %_NN
          Ethanol_NNP was_VBD added_VBN ,_, in_IN which_WDT cells_NNS were_VBD either_CC stored_VBD at_IN
          -_: 20_CD °_NN C_NNP for_IN up_IN to_TO three_CD days_NNS ,_, or_CC processed_VBD after_IN 20_CD minute_NN
          fixation_NN by_IN repelleting_VBG ._. Resuspension_NNP was_VBD done_VBN in_IN 1_CD ml_NN 2_CD
          N_NNP HCl_NNP /_NN 0_CD ._. 5_LS %_NN Triton_NNP X-_NNP 100_CD ,_, and_CC samples_NNS were_VBD incubated_JJ for_IN
          30_CD minutes_NNS at_IN room_NN temperature_NN with_IN vortexing_VBG every_DT five_CD
          minutes_NNS ,_, followed_VBN by_IN repelleting_VBG ._. After_IN removal_NN of_IN the_DT
          supernatant_NN ,_, nuclei_NN were_VBD resuspended_JJ in_IN 1_CD ml_NN 0_CD ._. 1_CD M_NNP Na_NNP 
          2_CD B_NNP 
          4_CD O_NNP 
          7_CD (_( pH_NN 8_CD ._. 5_LS )_) for_IN two_CD minutes_NNS at_IN room_NN
          temperature_NN ,_, and_CC washed_VBD with_IN 1_CD ml_NN 0_CD ._. 5_CD %_NN Tween-_NNP 20_CD /_NN 1_CD %_NN
          BSA_NNP /_NN PBS_NNP ._. Then_RB ,_, 20_CD μl_NN FITC-coupled_NNP anti-_NN BrdU_NNP antibody_NN
          (_( Becton-_NNP Dickinson_NNP )_) was_VBD added_VBN ,_, followed_VBN by_IN 30_CD minute_NN
          incubation_NN at_IN room_NN temperature_NN in_IN the_DT dark_NN ._. After_IN another_DT
          wash_NN with_IN 1_CD ml_NN 0_CD ._. 5_CD %_NN Tween-_NNP 20_CD /_NN 1_CD %_NN BSA_NNP /_NN PBS_NNP ,_, nuclei_NN were_VBD
          resuspended_JJ in_IN 0_CD ._. 25_CD ml_NN PBS_NNP containing_VBG 5_CD μg_NN /_NN ml_NN Propidium_NNP
          Iodide_NNP ,_, filtered_VBN through_IN 1_CD ._. 2_CD ml_NN Costar_NNP cluster_NN tubes_NNS
          (_( Costar_NNP #_# 4410_CD )_) ,_, or_CC 6_CD ml_NN tubes_NNS with_IN 35_CD μm_NN strainer_NN cap_NN
          (_( Falcon_NNP 2235_CD ,_, Becton-_NNP Dickinson_NNP )_) in_IN case_NN of_IN volumes_NNS
          greater_JJR than_IN 0_CD ._. 5_CD ml_NN ._. Flow_NNP cytometry_NN was_VBD done_VBN on_IN a_DT FACScan_NNP
          (_( Becton-_NNP Dickinson_NNP )_) and_CC results_NNS were_VBD analyzed_VBN using_VBG FlowJo_NNP
          software_NN (_( TreeStar_NNP )_) ._.
        
        
          Gene_NNP expression_NN studies_NNS
          To_TO measure_VB gene_NN expression_NN quantitatively_RB ,_, RNA_NNP was_VBD
          extracted_VBN from_IN primary_JJ rib_NN chondrocytes_NNS as_IN follows_VBZ :_: cells_NNS
          were_VBD harvested_VBN as_IN described_VBN above_IN ,_, rinsed_JJ in_IN PBS_NNP and_CC kept_VBD
          in_IN Trizol_NNP at_IN -_: 80_CD °_NN C_NNP ._. Extracts_NNP were_VBD thawed_JJ ,_, homogenized_JJ in_IN
          a_DT PowerGen_NNP 125_CD homogenizer_NN for_IN 1_CD minute_NN ,_, centrifuged_JJ at_IN
          2000_CD rpm_NN for_IN 30_CD seconds_NNS ._. The_DT supernatant_NN was_VBD transferred_VBN
          to_TO fresh_JJ tubes_NNS ,_, 20_CD %_NN of_IN volume_NN of_IN chloroform_NN was_VBD added_VBN ,_,
          and_CC the_DT sample_NN was_VBD vortexed_JJ for_IN 20_CD seconds_NNS ,_, followed_VBN by_IN
          centrifugation_NN at_IN 12000_CD rpm_NN for_IN 5_CD minutes_NNS at_IN 4_CD °_NN C_NNP ._. The_DT top_JJ
          layer_NN was_VBD removed_VBN to_TO fresh_JJ tubes_NNS for_IN precipitation_NN with_IN
          0_CD ._. 5_CD ml_NN Isopropyl_NNP Alcohol_NNP ,_, and_CC centrifuged_JJ at_IN 12000_CD rpm_NN
          for_IN 10_CD minutes_NNS at_IN 4_CD °_NN C_NNP ._. The_DT supernatant_NN was_VBD removed_VBN and_CC
          the_DT pellet_NN was_VBD washed_VBN three_CD times_NNS with_IN 75_CD %_NN EtOH_NNP ._. After_IN
          final_JJ removal_NN of_IN supernatant_NN ,_, the_DT pellet_NN was_VBD air_NN dried_VBD
          for_IN 1_CD -_: 2_CD minutes_NNS and_CC dissolved_VBN in_IN nanopure_NN H_NNP 
          2_CD O_NNP by_IN gentle_JJ pipetting_VBG and_CC ,_, where_WRB
          necessary_JJ ,_, by_IN incubation_NN at_IN 37_CD °_NN C_NNP for_IN 10_CD minutes_NNS ._. RNA_NNP
          concentration_NN was_VBD measured_VBN by_IN spectrophotometry_NN ._. Reverse_VBP
          transcription_NN of_IN RNA_NNP was_VBD performed_VBN using_VBG the_DT Superscript_NNP
          II_NNP first_JJ strand_NN synthesis_NN system_NN for_IN RT-PCR_NNP (_( Gibco_NNP BRL_NNP )_) ,_,
          following_VBG the_DT supplier_NN 's_POS instructions_NNS ._. Purification_NNP of_IN
          cDNA_NN was_VBD done_VBN using_VBG the_DT Qiagen_NNP PCR_NNP Purification_NNP Kit_NNP ,_, and_CC
          cDNA_NN concentration_NN was_VBD measured_VBN by_IN spectrophotometry_NN ._.
          Primers_NNP for_IN amplification_NN were_VBD designed_VBN using_VBG Primer_NNP
          Express_NNP software_NN (_( ABI_NNP )_) with_IN the_DT following_JJ parameters_NNS :_: TM_NNP
          requirements_NNS :_: min_NN ._. TM_NNP 58_CD °_NN C_NNP ,_, max_NN ._. TM_NNP 60_CD °_NN C_NNP ,_, optimal_NN TM_NNP
          59_CD °_NN C_NNP ;_: GC_NNP content_NN requirements_NNS :_: min_NN ._. %_NN GC_NNP 20_CD ,_, max_NN ._. %_NN GC_NNP 80_CD ;_:
          length_NN requirements_NNS :_: min_NN ._. length_NN 9_CD ,_, max_NN length_NN 40_CD ,_,
          optimal_NN length_NN 20_CD ;_: amplicon_NN requirements_NNS :_: min_NN ._. TM_NNP 0_CD °_NN C_NNP ,_,
          max_NN ._. TM_NNP 85_CD °_NN C_NNP ,_, min_NN ._. length_NN 50_CD ,_, max_NN ._. length_NN 150_CD ._. The_DT
          following_VBG primer_NN pairs_NNS (_( Genbank_NNP accession_NN numbers_NNS and_CC
          coordinates_VBZ on_IN the_DT mRNA_NN sequence_NN given_VBN in_IN brackets_NNS )_) were_VBD
          used_VBN to_TO amplify_VB the_DT specific_JJ cDNAs_NNS for_IN
          Bcl-_NNP 2_CD (_( NM_NNP __NN 009741_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: CGGAGACGAGTTCAACGAAAC-_NNP 3_CD '_POS (_( 681_CD -_: 701_CD )_) ;_: reverse_VB primer_NN :_:
          5_CD '_POS -_: TGTAAGATAACCATTTGAGGGTGG-_NNP 3_CD '_POS (_( 770_CD -_: 747_CD )_) ._.
          Bone_NNP Morphogenetic_NNP Protein-_NNP 2_CD (_( Bmp-_NNP 2_CD ;_: NM_NNP __NN 007553_CD )_) ;_:
          forward_RB primer_NN :_: 5_CD '_POS -_: CCTCAAGTCCAGCTGCAAGAG-_NNP 3_CD '_POS (_( 1223_CD -_: 1243_CD )_) ;_:
          reverse_VB primer_NN :_:
          5_CD '_POS -_: GGTGCCACGATCCAGTCATT-_NNP 3_CD '_POS (_( 1300_CD -_: 1281_CD )_) ._.
          Bone_NNP Morphogenetic_NNP Protein-_NNP 4_CD (_( Bmp-_NNP 4_CD ;_: D_NNP 14814_CD )_) ;_: forward_RB
          primer_NN :_: 5_CD '_POS -_: GCACTGCCGCAGCTTCTC-_NNP 3_CD '_POS (_( 5630_CD -_: 5647_CD )_) ;_: reverse_VB
          primer_NN :_:
          5_CD '_POS -_: CACTGACAGAAAACAAGGCATATAATAA-_NNP 3_CD '_POS (_( 5727_CD -_: 5700_CD )_) ._.
          Collagen_NNP II_NNP splice_NN form_NN A_DT (_( NM_NNP __NN 001844_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: AATGGGCAGAGGTATAAAGATAAGGA-_NNP 3_CD '_POS (_( 24_CD -_: 49_CD )_) ;_: reverse_VB primer_NN :_:
          5_CD '_POS -_: CATTCCCAGTGTCACACACACA-_NNP 3_CD '_POS (_( 99_CD -_: 78_CD )_) ._.
          Collagen_NNP X_NNP (_( X_NNP 67348_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: CAAACGGCCTCTACTCCTCTGA-_NNP 3_CD '_POS (_( 1937_CD -_: 1958_CD )_) ;_: reverse_VB primer_NN :_:
          5_CD '_POS -_: CGATGGAATTGGGTGGAAAG-_NNP 3_CD '_POS (_( 2065_CD -_: 2046_CD )_) ._.
          Dlx_NNP 5_CD (_( NM_NNP __NN 01156_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: ACGCGCGGAGTTGGC-_NNP 3_CD '_POS (_( 437_CD -_: 451_CD )_) ;_: reverse_VB primer_NN :_:
          5_CD '_POS -_: CTTGATCTTGGATCTTTTGTTCTGAA-_NNP 3_CD '_POS (_( 518_CD -_: 493_CD )_)
          Fibroblast_NNP growth_NN factor_NN receptor_NN 3_CD (_( Fgfr_NNP 3_CD ;_:
          NM_NNP __NN 008010_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: GAGTCTACACCCACCAGAGTGATGT-_NNP 3_CD '_POS (_( 2200_CD -_: 2224_CD )_) ;_: reverse_VB
          primer_NN :_: 5_CD '_POS -_: AGCCCCCCAGCGTAAAGAT-_NNP 3_CD '_POS (_( 2271_CD -_: 2253_CD )_) ._.
          Glyceraldehyde_NNP 3_CD -_: phosphate_NN dehydrogenase_NN (_( GAPDH_NNP ;_:
          Xm_NNP __NN 194302_CD )_) forward_RB primer_NN :_:
          5_CD '_POS -_: CCAGAACATCATCCCTGCATC-_NNP 3_CD '_POS (_( 674_CD -_: 694_CD )_) ;_: reverse_VB primer_NN :_:
          5_CD '_POS -_: GGTAGGAACACGGAAGGCC-_NNP 3_CD '_POS (_( 794_CD -_: 776_CD )_)
          Hoxc-_NNP 8_CD (_( NM_NNP __NN 010466_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: CAACACTAACAGTAGCGAAGGACAAG-_NNP 3_CD '_POS (_( 595_CD -_: 620_CD )_) ;_: reverse_VB
          primer_NN :_: 5_CD '_POS -_: CAAGGTCTGATACCGGCTGTAAGT-_NNP 3_CD '_POS (_( 727_NNP -_: 704_CD )_) ._.
          Indian_JJ hedgehog_NN (_( Ihh_NNP ;_: U_NNP 85610_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: CCCCAACTACAATCCCGACA-_NNP 3_CD '_POS (_( 543_CD -_: 562_CD )_) ;_: reverse_VB primer_NN :_:
          5_CD '_POS -_: TCATGAGGCGGTCGGC-_NNP 3_CD '_POS (_( 607_CD -_: 592_CD )_) ._.
          p_NN 107_CD (_( U_NNP 27177_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: TGGATTATTGAAGTTCTCGATTTGC-_NNP 3_CD '_POS (_( 1624_CD -_: 1648_CD )_) ;_: reverse_VB
          primer_NN :_: 5_CD '_POS -_: ATGCTGTTCAGATGTTTCACCATG-_NNP 3_CD '_POS (_( 1736_CD -_: 1713_CD )_)
          Parathyroid_NNP Hormone_NNP /_NN Parathyroid_NNP hormone_NN related_VBD
          peptide_NN Receptor_NNP (_( PTH_NNP /_NN PTHrP-R_NNP ;_: L_NNP 28108_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: GAAAGAATAAAGCAAAAGCGAGACA-_NNP 3_CD '_POS (_( 232_CD -_: 256_CD )_) ;_: reverse_VB primer_NN :_:
          5_CD '_POS -_: AGGGAGCTCTGACATCGGG-_NNP 3_CD '_POS (_( 299_CD -_: 281_CD )_) ._.
          Sox-_NNP 5_CD (_( NM_NNP 011444_CD )_) ;_: forward_RB primer_NN :_:
          5_CD '_POS -_: ATGGTGTGGGCGAAAGATGA-_NNP 3_CD '_POS (_( 1802_CD -_: 1821_CD )_) ;_: reverse_VB primer_NN :_:
          5_CD '_POS -_: GGCGGGCCTGCTCCT-_NNP 3_CD '_POS (_( 1946_CD -_: 1932_CD )_) ._.
          All_DT real-time_JJ PCR_NNP reactions_NNS were_VBD performed_VBN in_IN
          triplicate_NN on_IN an_DT ABI_NNP Prism_NNP 7000_CD in_IN SYBR_NNP Green_NNP Master_NNP Mix_NNP
          (_( Applied_NNP Biosystems_NNP )_) ,_, with_IN denaturation_NN at_IN 94_CD °_NN C_NNP for_IN 15_CD
          seconds_NNS ,_, annealing_VBG at_IN 55_CD °_NN C_NNP for_IN one_CD minute_NN and_CC extension_NN
          at_IN 60_CD °_NN C_NNP for_IN one_CD minute_NN in_IN a_DT total_NN of_IN 40_CD cycles_NNS ._. 100_CD nM_NN of_IN
          each_DT primer_NN were_VBD used_VBN and_CC 10_CD ng_NN of_IN template_NN cDNA_NN ._.
          Measurements_NNP were_VBD done_VBN in_IN triplicate_NN for_IN each_DT sample_NN ,_, and_CC
          for_IN each_DT sample_NN ,_, the_DT cycle_NN number_NN (_( Ct_NNP )_) was_VBD determined_VBN at_IN
          which_WDT signal_VBP above_IN threshold_NN was_VBD detected_VBN ._. The_DT values_NNS
          were_VBD averaged_VBN and_CC standardized_JJ to_TO measurements_NNS for_IN GAPDH_NNP
          cDNA_NN in_IN the_DT same_JJ sample_NN by_IN subtraction_NN :_: Ct_NNP 
          GENE_NNP -_: Ct_NNP 
          GAPDH_NNP =_SYM ΔCt_NN ._. This_DT value_NN for_IN each_DT gene_NN
          in_IN transgenic_JJ samples_NNS was_VBD then_RB normalized_JJ for_IN the_DT value_NN
          of_IN the_DT same_JJ gene_NN in_IN the_DT control_NN sample_NN by_IN a_DT second_JJ
          subtraction_NN :_: ΔCt_NN 
          transgenic_JJ -_: ΔCt_NN 
          control_NN =_SYM ΔΔCt_NN ._. The_DT value_NN for_IN "_'' fold_VB
          expression_NN "_'' relative_JJ to_TO the_DT control_NN is_VBZ obtained_VBN by_IN the_DT
          formula_NN f_SYM =_SYM 2_CD ΔΔCt_NN ._. The_DT resulting_VBG data_NN were_VBD expressed_VBN as_IN
          "_'' fold_VB change_NN "_'' relative_JJ to_TO the_DT gene_NN expression_NN level_NN in_IN
          the_DT control_NN which_WDT was_VBD prepared_VBN from_IN an_DT FVB_NNP mouse_NN ._.
        
      
    
  
